Other recent studies have shown that elevated levels of both sST2 and IL33 were associated with increased mortality in ST elevation myocardial infarction (STEMI), but IL33 did not predict mortality in patients with non-ST elevation myocardial infarction (NSTEMI), or stable angina [45,50]. This evidence concerns the gene IL33 and angina pectoris.